Literature DB >> 22262184

Does Δ133p53 isoform trigger inflammation and autoimmunity?

Hamish G Campbell1, Tania L Slatter, Aaron Jeffs, Reena Mehta, Carina Rubio, Margaret Baird, Antony W Braithwaite.   

Abstract

Autoimmune diseases are characterized by the immune system mounting a response against self. The exact etiology of autoimmune diseases and autoimmunity remain unclear. Here, we demonstrate that Δ133p53, an isoform of the tumor suppressor protein p53, is involved in the development of autoimmunity. We have previously generated a mouse model of Δ133p53 (Δ122p53). Δ122p53 mice develop an autoimmune/ inflammation-like phenotype that includes the production of autoantibodies, elevated levels of pro-inflammatory cytokines and lymphocyte aggregations in various organs. Microarray analysis reveals that expression of Δ122p53 induces a number of pro-inflammatory genes, including the STAT1 pathway and interferon-related transcription profile. Comparative genetic signatures have been observed in human SLE (systemic lupus erythematosus) patients, and we show that Δ133p53 regulates STAT1 in human cells. Our findings provide the first evidence of a role for p53 isoforms in the development of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262184     DOI: 10.4161/cc.11.3.19054

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Expression of p53β and Δ133p53 isoforms in different gastric tissues.

Authors:  Wansheng Ji; Na Zhang; Hongmei Zhang; Jingrong Ma; Hua Zhong; Jianxin Jiao; Zhixing Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

Review 3.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 4.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

Review 5.  A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation.

Authors:  Marina Kazantseva; Sunali Mehta; Ramona A Eiholzer; Noelyn Hung; Anna Wiles; Tania L Slatter; Antony W Braithwaite
Journal:  Mamm Genome       Date:  2018-07-10       Impact factor: 2.957

6.  Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.

Authors:  Sonal Sawhney; Kylie Hood; Alisha Shaw; Antony W Braithwaite; Richard Stubbs; Noelyn A Hung; Janice A Royds; Tania L Slatter
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

7.  Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.

Authors:  T L Slatter; N Hung; S Bowie; H Campbell; C Rubio; D Speidel; M Wilson; M Baird; J A Royds; A W Braithwaite
Journal:  Cell Death Dis       Date:  2015-06-11       Impact factor: 8.469

8.  p53 protein isoforms: key regulators in the front line of pathogen infections?

Authors:  Olivier Terrier; Jean-Christophe Bourdon; Manuel Rosa-Calatrava
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

Review 9.  Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity.

Authors:  Roman Uzhachenko; Anil Shanker; Wendell G Yarbrough; Alla V Ivanova
Journal:  Oncotarget       Date:  2015-08-28

10.  ∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling.

Authors:  Hamish Campbell; Nicholas Fleming; Imogen Roth; Sunali Mehta; Anna Wiles; Gail Williams; Claire Vennin; Nikola Arsic; Ashleigh Parkin; Marina Pajic; Fran Munro; Les McNoe; Michael Black; John McCall; Tania L Slatter; Paul Timpson; Roger Reddel; Pierre Roux; Cristin Print; Margaret A Baird; Antony W Braithwaite
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.